Presentation first given at the Digital Health Summit Turkey, Istanbul, December 17 2015. Focus of the presentation is the emerging role of physicians' social networks in supporting national health reform programmes and managing pandemic threats.
Why Physicians' Social Networks will be Crucial for Your Marketing StrategyLen Starnes
Presentation first given at Digipharm London, 29th September 2011. A global overview of physicians social networks, updating a similar overview presented in March 2009. Focus is on key learnings and major developments in USA, Europe and the Asia-Pacific region.
The Rise and Rise of HCPs' Social Networks - Focus on GCC RegionLen Starnes
Presentation given at the 5th Saudi eHealth Conference, Riyadh, 18 – 20 November 2014. The agenda includes: an update on the status of the continuing global expansion of HCPs’ social networks; a look at networks in the Gulf Cooperation Council (GCC) region; an overview of differentiating network characteristics; physicians’ usage patterns; impacts on national healthcare systems; and a case for the creation of a dedicated Saudi Arabian network to support the objectives of the country’s new healthcare reform.
An overview of the opportunities that physicians' social networks may offer pharmaceutical companies as an emergent new engagement channel in China. Includes analyses of current physicians' social networks in China, physicians' social networks as a global phenomenon, key learnings and Chinese scenarios. Presented at conferences in Shanghai in 2009 and Singapore in 2010. This version presented at EyeforPharma's Sales & Marketing in China for Pharma conference, 3 - 4 December 2009, Shanghai.
An update of earlier presentations on physicians' social networks, but with a focus on oncology, one of the most e-reliant specialities in medicine. First presented at Sales & Marketing for Oncology Therapeutics, Brussels, 16 March 2010.
Will global HCPs networks become communities of choice for rare-disease speci...Len Starnes
Analysis of the role of global HCPs' social networks in the management of rare diseases. Case study of the G-Med global neuroendocrine tumour specialist community
Keynote: The Future of Healthcare Events Len Starnes
Keynote presented at 'The Future of Healthcare Events Forum', Malmö, Sweden, 12 - 14 Feb 2019. Forum attendees were events professionals but insights have significant relevance for all healthcare stakeholders.
Why Physicians' Social Networks will be Crucial for Your Marketing StrategyLen Starnes
Presentation first given at Digipharm London, 29th September 2011. A global overview of physicians social networks, updating a similar overview presented in March 2009. Focus is on key learnings and major developments in USA, Europe and the Asia-Pacific region.
The Rise and Rise of HCPs' Social Networks - Focus on GCC RegionLen Starnes
Presentation given at the 5th Saudi eHealth Conference, Riyadh, 18 – 20 November 2014. The agenda includes: an update on the status of the continuing global expansion of HCPs’ social networks; a look at networks in the Gulf Cooperation Council (GCC) region; an overview of differentiating network characteristics; physicians’ usage patterns; impacts on national healthcare systems; and a case for the creation of a dedicated Saudi Arabian network to support the objectives of the country’s new healthcare reform.
An overview of the opportunities that physicians' social networks may offer pharmaceutical companies as an emergent new engagement channel in China. Includes analyses of current physicians' social networks in China, physicians' social networks as a global phenomenon, key learnings and Chinese scenarios. Presented at conferences in Shanghai in 2009 and Singapore in 2010. This version presented at EyeforPharma's Sales & Marketing in China for Pharma conference, 3 - 4 December 2009, Shanghai.
An update of earlier presentations on physicians' social networks, but with a focus on oncology, one of the most e-reliant specialities in medicine. First presented at Sales & Marketing for Oncology Therapeutics, Brussels, 16 March 2010.
Will global HCPs networks become communities of choice for rare-disease speci...Len Starnes
Analysis of the role of global HCPs' social networks in the management of rare diseases. Case study of the G-Med global neuroendocrine tumour specialist community
Keynote: The Future of Healthcare Events Len Starnes
Keynote presented at 'The Future of Healthcare Events Forum', Malmö, Sweden, 12 - 14 Feb 2019. Forum attendees were events professionals but insights have significant relevance for all healthcare stakeholders.
Digital disruption: What should patient organizations do to stay ahead?Len Starnes
Extended version of a presentation given at Roche's International Experience Exchange for Patient Organizations conference, Athens, 14 - 15 March, 2018. #IEEPO2018
A millennial generally refers to a person born between 1981 and 1997. In 2016, the Pew Research Center found that Millennials surpassed Baby Boomers to become the largest living generation in the United States. “Digital Native”. More likely to use the internet for research. How can social media help specialist medical practices stay competitive.
Connect After Clinic: How Digital Technologies Can Strengthen the Physician-P...Nisha Cooch, PhD
“Smart IT must accommodate, preserve, and uplift interpersonal relationships in health care.”
-Michael Weiner, MD, MPH & Paul Biondich, MD
The physician-patient relationship is an important but often overlooked contributor to patient health. Impressively, a good physician-patient relationship is just as important to health outcomes as the use of well-established medical interventions. It is therefore critical that physicians and patients alike commit to the development of this important connection and explore opportunities to strengthen it.
In this presentation, I discuss what contributes to a healthy physician-patient relationship, concerns about how technology may threaten it, and how to best leverage technology to improve it.
2018 has finally arrived, and healthcare companies’ executives from both small and big firms have hit the ground running. With technological artificial intelligence and new drugs in the industry, below are 6 healthcare predictions for 2018.
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
Ross McKenna
Portfolio Manager, Health System Infrastructure
Information Strategy and Architecture
National Health Board Business Unit
Ministry of Health
5 Ways Healthcare Brands Can Stand out to HCPs in the Digital EcosystemDRG Digital
Learn 5 ways healthcare brands can stand out to physicians in the digital ecosystem:
- Key physician trends and best practices you need to know for more effective campaigns
- New Manhattan Research Taking the Pulse® physician study findings
Deploying Telehealth to 1.2 M Users - LA County Case StudyVSee
Innovating Equitable Telehealth for LA County
The Los Angeles County Department of Mental Health (LACDMH) is the largest county-operated mental health department in the United States, directly operating 85+ programs and contracting with close to 1,000 organizations and individual practitioners. It’s goal is to reach 1.2M of its 10M residents who are in need of mental health services.
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Emergent hybrid medical society conferences: evidence of disruption; impact o...Len Starnes
Presentation first given at the 2015 Eyeforpharma Barcelona Conference; an update of a presentation given in 2013 on the emergent hybrid medical society physical/virtual conference format. Evidence of conference format disruption is presented based on the 2014 European Society of Cardiology Congress. The impact on the pharma industry is explored.
Digital disruption: What should patient organizations do to stay ahead?Len Starnes
Extended version of a presentation given at Roche's International Experience Exchange for Patient Organizations conference, Athens, 14 - 15 March, 2018. #IEEPO2018
A millennial generally refers to a person born between 1981 and 1997. In 2016, the Pew Research Center found that Millennials surpassed Baby Boomers to become the largest living generation in the United States. “Digital Native”. More likely to use the internet for research. How can social media help specialist medical practices stay competitive.
Connect After Clinic: How Digital Technologies Can Strengthen the Physician-P...Nisha Cooch, PhD
“Smart IT must accommodate, preserve, and uplift interpersonal relationships in health care.”
-Michael Weiner, MD, MPH & Paul Biondich, MD
The physician-patient relationship is an important but often overlooked contributor to patient health. Impressively, a good physician-patient relationship is just as important to health outcomes as the use of well-established medical interventions. It is therefore critical that physicians and patients alike commit to the development of this important connection and explore opportunities to strengthen it.
In this presentation, I discuss what contributes to a healthy physician-patient relationship, concerns about how technology may threaten it, and how to best leverage technology to improve it.
2018 has finally arrived, and healthcare companies’ executives from both small and big firms have hit the ground running. With technological artificial intelligence and new drugs in the industry, below are 6 healthcare predictions for 2018.
Digital Pharma: Evolution and Revolution in Marketing & SalesLen Starnes
A review for non-pharma audiences of evolutionary and revolutionary changes in pharma marketing and sales since the mid 90s. Presented at ENG's Effective Web Marketing and Search Engine Marketing conference, Brussels, November, 2007.
Ross McKenna
Portfolio Manager, Health System Infrastructure
Information Strategy and Architecture
National Health Board Business Unit
Ministry of Health
5 Ways Healthcare Brands Can Stand out to HCPs in the Digital EcosystemDRG Digital
Learn 5 ways healthcare brands can stand out to physicians in the digital ecosystem:
- Key physician trends and best practices you need to know for more effective campaigns
- New Manhattan Research Taking the Pulse® physician study findings
Deploying Telehealth to 1.2 M Users - LA County Case StudyVSee
Innovating Equitable Telehealth for LA County
The Los Angeles County Department of Mental Health (LACDMH) is the largest county-operated mental health department in the United States, directly operating 85+ programs and contracting with close to 1,000 organizations and individual practitioners. It’s goal is to reach 1.2M of its 10M residents who are in need of mental health services.
More and more health economies across the globe are deploying Electronic Health Records with some countries reaching full adoption by 2017. This means we, as healthcare marketers, now have a vital new channel to reach and educate decision makers.
Emergent hybrid medical society conferences: evidence of disruption; impact o...Len Starnes
Presentation first given at the 2015 Eyeforpharma Barcelona Conference; an update of a presentation given in 2013 on the emergent hybrid medical society physical/virtual conference format. Evidence of conference format disruption is presented based on the 2014 European Society of Cardiology Congress. The impact on the pharma industry is explored.
Healthcare Social Networking: Is Pharma Ready to Join the Conversation?Len Starnes
A pragmatic assessment of the impact of social networking on pharma marketing & sales. Includes analyses of HCPs' social networks, consumer/patient social networks and the convergence of PR with SEO and SEM. Presented at conferences in Zurich, Shanghai and Boston during 2008. This version presented at EyeforPharma's
E-Communications and Online Marketing Summit, Boston, 2008.
Virtual Conferencing: A Roadmap for PharmaLen Starnes
A pragmatic Roadmap for the pharmaceutical and medtech industries to digitize their conference and events channels. Presentation is a follow-up to an earler deck: 'The Medical Conference is Dead. Long Live the Medical Conference'.
An outline of data collected from European doctors (via Doctors.net.uk and M3 Global Research) looking at the impact of the Internet on healthcare and the expectations for the future
A sobering but enlightening journey from eMarketeer to ePatient...and back againLen Starnes
Presentation first given at Doctors 2.0 and You, Paris May 24, 2012.
A personal account of being both a pharma eMarketeer and an ePatient. Includes learnings for pharma:
Ocular Disorders-Insight Pharma ReportsDaniel Miller
Available to Insight Pharma Reports is Ocular Disorders: Rising Therapeutics, Technologies, and Devices Report. This report begins with outlining Age-related macular degeneration (both wet and dry) and delving into Anti-VEGF therapies in chapter 2. Further providing substantial weight to this report, several companies were interviewed on their approach to targeting wet and dry AMD, their strategies for seeking alternative therapeutic options, and the hardships they have encountered in their research and product execution.
Healthcare Professionals' Social Networks: The Beginning of the End of Pharma...Len Starnes
First presented at Digital Pharma Europe, Barcelona, 31st March 2009.
Captures the current status of healthcare professionals' social networks from a global perspective and a pharmaceutical industry marketing & sales perspective
Best practices for pharmaceutical training seminars and employee engagementJack Morton Worldwide
The healthcare landscape is changing dramatically. New technologies have the potential to revolutionize how pharma training is delivered.
But what’s the right balance of new technologies and proven training methodology?
We explore this topic in our newest white paper, The Changing Face of Pharma Training.
Dear Students
We can help you to write total dissertation/project report.
Our 9 step method of project writing:-
Step 1) Helping you in Selection of topic.
Step 2) Group discussion / conference call with in team of professors.
Step 3) Helping you in Preparation of Synopsis/ proposal & sent to project guide
HealthCursor Consulting Group India- Mobile Health is going to be a 3000 crore market in India by 2017. (Source PwC). M-health (use of mobile phones) and E-health are all set to make an entry into India's primary health centres (PHCs) and sub-centres as the health ministry plans to go hi-tech. Healthcare industry is expected to show a strong growth of 23% per annum to become a US$ 77 billion industry by 2012. One of the largest sector in terms of revenue and employment has grown at 9.3% per annum between 2000-2009 with a current size at par with fastest growing developing country like China, Brazil and Mexico.Driven by various catalysts such as increasing population, rising income levels, changing demographics and illness profile with a shift from chronic to life style diseases, healthcare industry is expected to move to levels of US$ 77 billion in next 3 years. (Source: ASSOCHAM).
Empowering rural India is of utmost importance and the government needs to do so by provisioning for broadband penetration and financial inclusion. Access to quality health care is another key to achieving rural empowerment. The budget for this segment was raised marginally last year and it would be good to have an allocation for rural health care programs with provisions for technology that would help modernize this sector to expand its reach through remote healthcare solutions and telemedicine.
Furthermore, the government announced a big budget campaign 'Swabhimaan' in the budget last year to promote banking and provide services to about 20,000 villages. In order to meet this goal, the budget this year too would need to make provisions accordingly. The steering committee on health said that in the 12th plan (2012-17), all district hospitals would be linked to leading tertiary care centres through telemedicine, Skype and similar audio visual media. M-health will be used to speed up transmission of data. Disease surveillance will be put on a GIS platform.
Disease surveillance based on reporting by providers and clinical laboratories (public and private) to detect and act on disease outbreaks and epidemics would be an integral component of the system.India will also put in place a Citizen Health Information System (CHIS) - a biometric based health information system which will constantly update health record of every citizen-family. The system will incorporate registration of births, deaths and cause of death. Maternal and infant death reviews, nutrition surveillance, particularly among under-six children andwomen, service delivery in the public health system, hospital information service besides improving access of public to their own health information and medical records would be the primary function of the CHIS.
Economies of Indian states can grow 1.08 per cent faster with every 10 per cent increase in Internet and broadband connections.
Healthcare is undergoing a transformation. Consumers want to make informed choices and take control of their lives, and pharma companies must be ready to meet their needs. This means building a new healthcare ecosystem that places the patient at its center, with the “person” fully engaged in his or her own healthcare. But with this move to person-centric healthcare, payers and providers are no longer the main decision makers.
So what does this mean for today’s marketers?
In this exclusive Social On Us webinar we discuss:
- Where marketing is failing to address healthcare concerns
- How “big data” is a change-driver for a new healthcare ecosystem
- New opportunities for predictive and preventative medical intervention
- Impact of digital healthcare on patient privacy
Collaborative Digital Pharma Marketing: A Role Model for Asia Pacific Healthc...Len Starnes
Presentation first given 10th March 2011 in Singapore at the Campaign Spotlight 'From Drugs to Brands' conference. Reviews the potential of collaborative marketIng in the Asia Pacific region with focus on physicians and patients.
Un nuovo perspective dedicato all'importanza della trasparenza nel settore sanità, con un confronto internazionale - A cura di Daniela Scaramuccia, Partner, e Nunzio Guida, Associate dell'ufficio di Milano Dicembre
Why Precision Medicine and Personalized Healthcare and Why Now? Links to Canada’s Rare Disease Strategy The Future is Now
1) Marc LePage, Genome Canada
2) Michael Duong, Roche
3) Danica Stanimirovic, National Research Council
4) Daniel Gaudet, University of Montreal
5) Christine Dalgleish, Patient Perspective
6) Jamie Bruce, Khure Health
People with Chronic Disease needs complete care. The current patient experience will be enhanced with the available technology and by figuring out the ageing population and rising incidence of Chronic Diseases.
The new normal is already here. A 'new' new normal loomsLen Starnes
This presentation is an update to a 2-part review of disrupted medical conferences published on Pharmaphorum March 15th and 16th 2022 .
It reflects recent trends and current disruptive global warnings, events, and threats likely to further impact medical meetings
Disrupted medical conferences: THE BIG PICTURELen Starnes
An in-depth analysis of the impact of covid on medical conferences: lessons learnt 2020-2021; consequences for all major stakeholders 2022; scenarios for 2022 and beyond. A visual abstract presents the full analysis.
Disrupted Medical Conferences: What does it mean for Italian pharmas?Len Starnes
Presentation given during a Merqurio.it webinar 26 March 2021. Outlines the implications of covid-disrupted medical society conferences for the Italian pharma industry and the pharma industry in general: likely conference formats 2021; emerging formats 2022 and beyond; % Italian doctors attending major events; hybrid complexity from a pharma perspective; 4 key pharma survival strategies.
The future of scientific congresses: what can we learn from the medical world?Len Starnes
Keynote presentation given during the November 26 Digital University Day organized by the Delft University of Technology, The Netherlands. Focuses on the transformation of medical society congresses to virtual formats during 2020, highlighting outcomes relevant for academic science and technology events.
شبكات تواصل اجتماعي للأطبّاءتعزيز معايير الرعاية الطبّيّة دعم برامج الرعاية...Len Starnes
عرض تقديمي يقدّم للأطبّاء من منطقة الشرق الأوسط وشمال إفريقيا ودول مجلس التعاون الخليجي يوضّح مكانة شبكات الأطبّاء الاجتماعيّة في العالم وتأثيرها على ممارسة مهنة الطبّ. تركيز خاصّ على إمكانيّات الشبكات الكامنة في منطقة الشرق الأوسط وشمال إفريقيا ودول مجلس التعاون الخليجي، مع التركيز على الفرص التي تقدّمها لدعم برامج الإصلاحات الوطنيّة في مجال الرعاية الطبيّة. دروس ومقارنات من الصين.
Doctors' Social Networks: Boosting standards of medical care. Supporting heal...Len Starnes
Presentation given to doctors from the MENA/GCC region outlining the scale of doctors’ social networks worldwide and their impact on the practice of medicine. Special focus on the potential of networks in the MENA/GCC region, highlighting opportunities they offer to support national healthcare reform programmes. Lessons and parallels from China.
Going social: why patient organizations cannot ignore social media Len Starnes
Presentation goven at the 7th Annual International Experience Exchange for Patient Organizations, Munich, 3 - 4 March 2015; #IEEPO2015. The event was sponsored by Roche.
Some 300 participants attended representing over 40 patient organizations worldwide. The final day of the meeting was dedicated to social media and how they can help patient organizations achieve their goals
This presentation served as the basis of a Twitter reporter training programme developed for the 2014 European Society of Cardiology Congress which took place in Barcelona August 30th to September 3rd.
It asks the question: what is a ‘valuable tweet’ in the context of a medical society conference? It further explores the ontology of tweets that could be regarded as valuable during medical meetings and conferences.
Whilst the issue of the use of Twitter at medical conferences has been intensively discussed during recent years, the focus of the dialogue has primarily been the nature and scale of the disruption on traditional physical conference formats. By contrast, this presentation explores the qualitative nature of tweets that add value to scientific debate.
Comments on this presentation would be most welcome.
Presentation delivered at the Russian Pharmaceutical Forum, St Petersburg, 17 - 19 June 2014, an update of a presentation first delivered in 2012: 'Making sense of multichannel'. The focus is on the progress of pharma multichannel marketing during the period 2012 to 2014, highlighting frequently cited hurdles, significant common practices, and emerging trends.
#ChatAfib: Pharma industry's first-ever open tweet chatLen Starnes
Analysis of the pharma industry's first.ever tweet chat: Boehringer Ingelheim's #ChatAfib, staged during the 2013 European Society of Cardiolgy Congress. The first of two presentations exploring the impact of social media and digital technologies on professional medical conferences
Introductory presentation to an EphMRA Masterclass workshop follow-up webinar given 6 December 2012. The original Masterclass workshop was delivered in Paris June 2012 at the EphMRA '360 Future' conference.
This translation was made possible with the kind and generous help of Jahee Lee, Dreamwiz, Korea. www.dreamwiz.com
In Korean: Making Sense of Multichannel (in the pharma industry)Len Starnes
Presentation first given at the Digital Health Summit Turkey, Istanbul, 11 – 12 September 2012. This was the first event of its type in Turkey with representatives of all major healthcare stakeholders: HCPs, patients, pharma, payers, government, academia, regulators, digital agencies and the media. Some 200 delegates participated.
http://www.ptms.com.tr/
This translation was made possible by the kind and generous help of Jahee Lee, Dreamwiz, Korea. www.dreamwiz.com
In Russian: The Digital Metamorphosis of the Pharma Industry Len Starnes
Russian translation of a presentation first given at the Pharma Digital Marketing Summit, Istanbul, February 2012. This translation was made possible by the kind and generous help of Oxana Kolosova, Managing Partner of iVrach: www.ivrach.com.
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
The prostate is an exocrine gland of the male mammalian reproductive system
It is a walnut-sized gland that forms part of the male reproductive system and is located in front of the rectum and just below the urinary bladder
Function is to store and secrete a clear, slightly alkaline fluid that constitutes 10-30% of the volume of the seminal fluid that along with the spermatozoa, constitutes semen
A healthy human prostate measures (4cm-vertical, by 3cm-horizontal, 2cm ant-post ).
It surrounds the urethra just below the urinary bladder. It has anterior, median, posterior and two lateral lobes
It’s work is regulated by androgens which are responsible for male sex characteristics
Generalised disease of the prostate due to hormonal derangement which leads to non malignant enlargement of the gland (increase in the number of epithelial cells and stromal tissue)to cause compression of the urethra leading to symptoms (LUTS
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
These lecture slides, by Dr Sidra Arshad, offer a quick overview of physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar leads (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Physicians' Social Networks: A New Tool in Global Health
1. Physicians’ social networks
A new tool in global health
Len Starnes
Digital healthcare consultant
Digital Health Summit Turkey
Istanbul
17 – 18 December 2015
3. Why do doctors use?
Trust in confidentiality
of closed networks
Seeking 2nd opinion
on diagnoses & treatment
Monitoring latest
research findings Discussing health
policy issues
Catching up
with colleagues
Participating in
CME programmes
29. Network proposal to support
KSA Health Reform*
Public/Private partnership
Integration with clinical
& admin workflows
Interoperability with EHRs
Comprehensive CME
resources
*Presented at 5th Saudi eHealth Conference, Riyadh, 18 – 20 November 2014
http://www.slideshare.net/lenstarnes/saudi-e-health-conf-nov-2014public-final24-nov
33. Dr James Wilson
Director Centre of Infectious Disease Forecasting
University of Nevada-Reno
‘
’
Ebola and the recent measles
epidemic have shown us that
disease outbreaks have no
borders…
34. ‘
’
Contagion travels at jet speed
between busy airports
*A geometric approach to network-driven contagion phenomena,
Dirk Brockmann, http://rocs.hu-berlin.de/projects/hidden
36. The most egregious
failure was by WHO in
the delay in sounding
the alarm…
Ashish K. Jha
Director Harvard Global Health Institute
‘
’
37. One thing is clear: we need to
decentralize information and have
open discussion with the world's
frontline healthcare providers
Dr James Wilson
Director Centre of Infectious Disease Forecasting
University of Nevada-Reno
‘
’
39. Solving difficult patient cases
Education on new medical
techniques & approaches
Safe place to talk with other
physicians
2015
Attitudes shifting towards
use of global networks*
*Based on Sermo survey of 1360 physicians in 7 countries, 2015
42. Decentralize information
Connect the right information at the right time
with the right people
Increase resilience
Bypass official alerting & response mechanisms
Eliminate 'politics'
Remove threat of 'being wrong' for health officials
who are politically exposed
Social networks enable
43. …communication between doctors in
the face of the next global health
crisis will not only be of utmost
importance, it could be the key to
saving lives on a truly massive scale.
Dr James Wilson
Director Centre of Infectious Disease Forecasting
University of Nevada-Reno
‘
’
44. lenstarnes@gmail.com
T: + 49 30 781 5513
M: + 49 172 1788253
Skype: lenstarnes
www.linkedin.com/in/lenstarnes
www.twitter.com/lenstarnes
www.slideshare.net/lenstarnes
Len Starnes
Len Starnes Digital Healthcare
Research & Consulting
45. A sincere thanks to the following for their
support in developing this presentation
• Dr Erden Asena
Founder & CEO DoktorSitesi.com
@doktorsitesi
• Dr Linda Girgis
Family physician, New Jersey, USA
@DrLindaMD
• Dr James Wilson
Director, Centre of Infectious Disease Forecasting, University of
Nevada-Reno
Co-Founder and Director, Ascel Bio National Infectious Disease
Forecast Station
@iceaxe5